Clinical Trials on Small Lymphocytic Leukemia (SLL)
Total 15695 results
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Safety and Tolerability | Compare SHINGRIX Vaccine Response RatesUnited States
-
Genentech, Inc.AbbVie (prior sponsor, Abbott)CompletedLymphocytic Leukemia, ChronicUnited States, United Kingdom
-
Hoffmann-La RocheTerminatedLymphocytic Leukemia, ChronicRussian Federation
-
Hoffmann-La RocheTerminatedLymphocytic Leukemia, ChronicRussian Federation
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicFrance
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicSweden
-
Pharmacyclics LLC.TerminatedLeukemia | Leukemia, Lymphocytic, ChronicUnited States
-
BioCryst PharmaceuticalsCompletedLeukemia, Lymphocytic, ChronicUnited States
-
Abcuro, Inc.RecruitingT-cell Large Granular Lymphocytic LeukemiaUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Northwell HealthTerminated
-
CytRxCompletedB-Cell Chronic Lymphocytic LeukemiaUnited States
-
Cylene PharmaceuticalsWithdrawnB-Cell Chronic Lymphocytic LeukemiaUnited States
-
National Health Research Institutes, TaiwanCompletedChronic Lymphocytic Leukemia (CLL)
-
XEME Biopharma Inc.National Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia (CLL)United States
-
University Health Network, TorontoNovartisCompletedChronic Lymphocytic Leukemia (CLL)Canada
-
MedImmune LLCCompletedChronic Lymphocytic Leukemia (CLL)United States, France, Italy, Poland, Canada, Israel, Germany, Belgium
-
Gilead SciencesApproved for marketingChronic Lymphocytic Leukemia (CLL)United States, Italy, United Kingdom, Ireland
-
AbbVieTerminatedChronic Lymphocytic Leukemia (CLL)Russian Federation
-
Pharmacyclics LLC.Janssen, LPCompletedChronic Lymphocytic Leukemia (CLL)United States
-
Gilead SciencesBoehringer IngelheimTerminatedChronic Lymphocytic Leukemia (CLL)United States
-
University of PeloponneseNational and Kapodistrian University of Athens; Harokopio UniversityCompleted
-
Merck Sharp & Dohme LLCCompletedChronic Lymphocytic Leukemia (CLL)
-
BioCryst PharmaceuticalsCompletedChronic Lymphocytic Leukemia (CLL)United States, Australia
-
Nevada Cancer InstituteGlaxoSmithKline; CephalonTerminatedChronic Lymphocytic Leukemia (CLL)United States
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone Lymphoma | Waldenström Macroglobulinemia and other conditionsUnited States
-
Steven E. CoutreBayerCompletedLeukemia | Chronic Lymphocytic Leukemia (CLL) | Chronic Leukemia | B-cell LeukemiaUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | Relapsed Adult ALL | Relapsed CLL | Refractory B-Cell Small Lymphocytic LymphomaUnited States
-
Karolinska University HospitalSchering Nordiska ABCompleted
-
Eastern Cooperative Oncology GroupCompletedAdult Patients (Over 55) With Acute Non-Lymphocytic Leukemia
-
Jennifer WoyachKaryopharm Therapeutics IncActive, not recruitingRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
AbbVieActive, not recruitingCancer - Chronic Lymphocytic LeukemiaFrance
-
Hoffmann-La RocheTerminatedB-Cell Chronic Lymphocytic LeukemiaItaly, Spain, Israel, United Kingdom, Latvia
-
Prof. Dr. Med. Laimonas GriskeviciusCompletedB-Cell Chronic Lymphocytic LeukemiaLithuania
-
CelgeneCompletedLeukemia Lymphocytic Chronic B-CellUnited States, Austria
-
CelgeneCompletedB-Cell Chronic Lymphocytic LeukemiaUnited States, Spain, Australia, Belgium, Italy, Serbia, Poland, Israel, New Zealand, Portugal, Brazil, France, Bulgaria, Croatia, Czechia, Hungary, Russian Federation, Netherlands, Romania, Denmark, United Kingdom, Austria, Canada, South... and more
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedRefractory Chronic Lymphocytic LeukemiaUnited States
-
Janssen-Cilag Farmaceutica Ltda.Approved for marketingB-cell Chronic Lymphocytic LeukemiaBrazil
-
Ohio State University Comprehensive Cancer CenterAstex Pharmaceuticals, Inc.CompletedB-Chronic Lymphocytic LeukemiaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)Withdrawn
-
SBI Biotech Co., Ltd.Terminated
-
Genzyme, a Sanofi CompanyCompletedB-Cell Chronic Lymphocytic LeukemiaSweden, United States, Croatia, Canada, Ukraine, Austria, Bulgaria, France, Germany, Greece, Italy, Poland, Portugal, Romania, Russian Federation
-
BayerCompleted
-
BiogenTerminatedB-Cell Chronic Lymphocytic LeukemiaUnited States
-
Chronic Lymphocytic Leukemia Research ConsortiumBayerUnknownB-Cell Chronic Lymphocytic LeukemiaUnited States
-
Genitope CorporationTerminatedB-Cell Chronic Lymphocytic Leukemia
-
TG Therapeutics, Inc.TerminatedMantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Waldenstrom's Macroglobulinemia | Non-Hodgkins Lymphoma | Small Lymphocytic Lymphoma | B-cell LymphomasUnited States
-
French Innovative Leukemia OrganisationCompletedB Cell Chronic Lymphocytic LeukemiaFrance
-
Arbeitsgemeinschaft medikamentoese TumortherapieSchering-PloughCompletedB-cell Chronic Lymphocytic LeukemiaAustria